Literature DB >> 9809547

Regulation of host immune responses by modification of Salmonella virulence genes.

J L VanCott1, S N Chatfield, M Roberts, D M Hone, E L Hohmann, D W Pascual, M Yamamoto, H Kiyono, J R McGhee.   

Abstract

Modifying bacterial virulence genes to probe the nature of host immunity is mostly unexplored. Here we investigate whether host immune responses can be regulated by modification of bacterial virulence genes. In mice, attenuated Salmonella mutant strains with clinical relevance elicited differential host immune responses. Oral administration of a mutant strain with a PhoP-null phenotype promoted potent innate immune responses of macrophages that were sufficient for host defense. In contrast, administration of an Aro- mutant strain elicited stronger specific antibody and T-helper (Th)-cell responses, wherein Th1-type cells were required for clearance. Thus, genetic manipulation of bacteria may be used to broadly alter immune mechanisms that regulate attenuation within the host and to tailor host immunity to specific bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809547     DOI: 10.1038/3227

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  52 in total

Review 1.  Interleukin 12 and innate molecules for enhanced mucosal immunity.

Authors:  P N Boyaka; J W Lillard; J McGhee
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  IFNs and STATs in innate immunity to microorganisms.

Authors:  Thomas Decker; Silvia Stockinger; Marina Karaghiosoff; Mathias Müller; Pavel Kovarik
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 3.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition.

Authors:  Alberto Diaz-Quiñonez; Natalia Martin-Orozco; Armando Isibasi; Vianney Ortiz-Navarrete
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cells.

Authors:  Andreas Kupz; Greta Guarda; Thomas Gebhardt; Leif E Sander; Kirsty R Short; Dimitri A Diavatopoulos; Odilia L C Wijburg; Hanwei Cao; Jason C Waithman; Weisan Chen; Daniel Fernandez-Ruiz; Paul G Whitney; William R Heath; Roy Curtiss; Jürg Tschopp; Richard A Strugnell; Sammy Bedoui
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606

6.  Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.

Authors:  Seung-Joo Lee; Joseph Benoun; Brian S Sheridan; Zachary Fogassy; Oanh Pham; Quynh-Mai Pham; Lynn Puddington; Stephen J McSorley
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

7.  Attenuated Salmonella typhimurium reduces ovalbumin-induced airway inflammation and T-helper type 2 responses in mice.

Authors:  C-J Wu; L-C Chen; M-L Kuo
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 8.  Salmonella infection: Interplay between the bacteria and host immune system.

Authors:  Jonathan R Kurtz; J Alan Goggins; James B McLachlan
Journal:  Immunol Lett       Date:  2017-07-15       Impact factor: 3.685

9.  Balance of Irgm protein activities determines IFN-gamma-induced host defense.

Authors:  Stanley C Henry; Xiaoju G Daniell; Ashley R Burroughs; Maanasa Indaram; David N Howell; Jörn Coers; Michael N Starnbach; Julia P Hunn; Jonathan C Howard; Carl G Feng; Alan Sher; Gregory A Taylor
Journal:  J Leukoc Biol       Date:  2009-01-27       Impact factor: 4.962

10.  Tissue selectivity of interferon-stimulated gene expression in mice infected with Dam(+) versus Dam(-) Salmonella enterica serovar Typhimurium strains.

Authors:  Ronit Shtrichman; Douglas M Heithoff; Michael J Mahan; Charles E Samuel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.